Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Liang Zhang has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    P2X7R of synovial fibroblasts is a potential therapeutic target associated with refractory rheumatoid arthritis

    by Peishi Rao, Shanzhao Jin, Shibai Xiao, Yinchao Ma, Jing Li, Yuhua Liao, Ziye Wang, Yundi Tang, Xuanlin Cai, Xingyue Zeng, et al.

    Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovitis. Synovial fibroblasts (SF) are the predominant cellular components in the inflamed synovium. Recent studies have shown increased expression of P2X7 receptor (P2X7R) in RA SF. However, its precise expression patterns and its contribution to inflammatory arthritis remain unclear. We demonstrate that P2X7R is robustly expressed in RA synovium, correlating with increased synovitis and systemic inflammation. Single-cell transcriptome analysis indicated that P2X7R was enriched in specific SF associated with refractory RA. Then, we applied a highly selective human P2X7R antagonist, EVT-401, which promoted apoptosis and induced cell cycle arrest in RA SF, reduced the production of proinflammatory and joint-destructive mediators, and mitigated aggressive phenotypes. Furthermore, we demonstrated that EVT-401 markedly reduced synovial inflammation and arthritis severity in a nonhuman primate model of autoimmune arthritis. Together, these findings suggest that P2X7R is involved in synovial inflammation and its inhibition may represent a potential therapeutic strategy for refractory RA.


  • Open Access

    Clinical and radiological outcomes of direct anterior versus posterolateral total hip arthroplasty in ankylosing spondylitis: A propensity-matched study

    by Xingshan Wang1, Shaoyi Guo1, Dazhao Chen, Yixin Zhou, Tao Bian, Siliang Man, Liang Zhang

    Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.


  • Open Access

    Clinical characteristics and treatment patterns in ankylosing spondylitis patients undergoing total hip arthroplasty: a single-center retrospective cohort study with a two-decade comparative analysis (2001–2023)

    by SiLiang Man, XiaoJian Ji, YingYue Ding, HongChao Li, Wei Liu, ShaoYi Guo, Tao Bian, Liang Zhang

    Despite advances in medical treatment for ankylosing spondylitis (AS), total hip arthroplasty (THA) remains essential for managing advanced hip involvement

  • Open Access

    The Impact of Preoperative Inflammatory Activity in Patients with Ankylosing Spondylitis on Postoperative Joint Function: A Retrospective Cohort Study

    by Si-Liang Man, Xiao-Jian Ji, Ying-Yue Ding, Hong-Chao Li, Shao-Yi Guo, Tao Bian, Liang Zhang

    The relationship between preoperative inflammatory activity and postoperative functional outcomes following total hip arthroplasty (THA) in patients with ankylosing spondylitis (AS) has not been fully elucidated. This study aimed to evaluate the predictive value of preoperative inflammatory markers for postoperative functional outcomes in patients with AS undergoing THA. Methods: Employed a retrospective research method. A total of 541 AS patients (739 hips) who underwent primary THA between 2003 and 2019 were analyzed. Preoperative inflammatory markers, including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), fibrinogen (FIB), and D-dimer (D-D), were measured. Functional outcomes were assessed using the Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and Harris Hip Score (HHS). Results: Patients with higher baseline ESR levels experienced greater functional improvement postoperatively. Specifically, a higher baseline ESR was associated with an increased probability of BASFI improvement, with an adjusted relative risk of 0.72 per unit increase in ln(ESR). Clinically meaningful improvements were observed, with BASFI decreasing by an average of 18.5 points and HHS increasing by 46.2 points, both exceeding minimal clinically important differences. Conclusion: These findings suggest that elevated preoperative inflammatory markers, particularly ESR, are not contraindications for THA in AS patients. Instead, they may indicate a greater capacity for postoperative functional recovery. The study supports a proactive surgical approach in appropriately selected AS patients, emphasizing the need for individualized assessment and consideration of systemic inflammation as a potential marker of postoperative improvement rather than a barrier to surgical intervention. These insights could refine surgical decision-making and optimize timing for THA in AS patients.

  • Open Access

    Evolving Characteristics of Rheumatoid Arthritis Patients Receiving Primary Hip or Knee Arthroplasty: A 21‐Year Single‐Center Trend Analysis (2002–2022)

    by Xingshan Wang, Shaoyi Guo, Liang Zhang, Cong Ma, Bei Wang, Qin Zhang, Hongchao Li, Siliang Man

    Objective: Although advances in disease‐modifying therapies have improved rheumatoid arthritis (RA) management, many patients still require total hip or knee arthroplasty. Long‐term data on baseline characteristics and treatment patterns of RA patients undergoing arthroplasty in China are scarce. This study aimed to investigate time trends in baseline demographic, clinical, laboratory, and treatment parameters of RA patients undergoing THA and TKA between 2002 and 2022. Methods: A retrospective study of consecutive THAs and TKAs for RA patients between 2002 and 2022 was conducted at a single center. The preoperative patient demographics, clinical and laboratory parameters were collected. All joints were divided into 2002–2011 and 2012–2022 groups, THA and TKA groups, juvenile‐onset rheumatoid arthritis (JORA) (0–16 years), adult‐onset rheumatoid arthritis (AORA) (16–60 years), and late‐onset rheumatoid arthritis (LORA) (≥ 60 years) groups, respectively. The intergroup comparisons were performed. Results: A total of 1363 primary TKAs in 897 patients with RA and 561 hips in 511 patients with RA were included. The number of arthroplasties performed annually from 2002 to 2022 demonstrated a significantly increasing trend. The use of glucocorticoids (GCs) before surgery demonstrated a significant decreasing trend while conventional synthetic disease‐modifying anti‐rheumatic drugs (csDMARDs) and biological DMARDs (bDMARDs) + targeted synthetic DMARDs (tsDMARDs) demonstrated an increasing trend. Comparison by time period (2002–2011 vs. 2012–2022) showed that the percentage of preoperative use of csDMARDs and bDMARDs + tsDMARDs was significantly higher and GCs were significantly higher in the 2002–2011 group. Conclusions: The number of THAs and TKAs performed annually from 2002 to 2022 demonstrated a significantly increasing trend in a tertiary care center for musculoskeletal diseases. In contrast, a significantly increasing trend for the percentage of preoperative use of csDMARDs and bDMARDs + tsDMARDs and a significantly decreasing trend for preoperative use of GCs and inflammatory markers was identified.

  • [A follow-up study on total hip arthroplasty in patients with systemic lupus erythematosus combined with osteonecrosis of femoral head].

    by Xiaolin Wang, Shaoyi Guo, Dazhao Chen, Xijie Wen, Yong Hua, Liang Zhang, Qin Zhang

    To evaluate the clinical results of total hip arthroplasty (THA) for the treatment of patients with systemic lupus erythematosus (SLE) with end-stage osteonecrosis of femoral head (ONFH). Between March 2002 and June 2024, 235 SLE patients with end-stage ONFH who underwent 340 THAs were retrospectively reviewed. Before operation and at the last follow-up visit, the patient demographics, disease-related, hip and surgery-related, and laboratory parameters were collected via outpatient questionnaire, telephone, and online questionnaire. Objective clinical results were evaluated using the Harris hip score (HHS) system and subjective clinical results were evaluated using the short form-12 (SF-12) outcome score. The patient satisfaction at the last follow-up was evaluated by using a four-point scale with the options "very unsatisfied", "unsatisfied", "satisfied", or "very satisfied". The median duration of follow-up was 58.0 (34.7, 101.2) months (12.4-283.2 months). At the last follow-up, the HHS increased from 32.0 (23.8, 39.3) before surgery to 88.0 (84.0, 91.0), the SF-12 mental component score (MCS) increased from 42.3(35.7, 48.7) before surgery to 52.3 (47.8, 55.9) and the SF-12 physical component score (PCS) increased from 36.8 (28.3, 43.4) before surgery to 52.0 (46.7, 54.5) (all P < 0.001). Evaluation of the hip satisfaction at the last follow-up showed that 58.8% (200 hips) were very satisfied, 35.3% (120 hips) were satisfied, 4.1% (14 hips) were less satisfied, 1.8% (6 hips) were very unsatisfactory, and the overall satisfaction rate was 94.1%. The postoperative systemic complications included pulmonary infection in 6 hips (1.8%), urinary tract infection in 10 hips (2.9%), cholecystitis in one hip (0.3%), intracranial infection in one hip (0.3%), cerebral infarction in 2 hips (0.6%), pulmonary embolism in 2 hips (0.6%), and atrial fibrillation in 2 hips (0.6%). Consequently, all hips were divided into those with systemic complications (25 hips) and those without systemic complications (315 hips). The results of intergroup comparisons showed significant differences in preoperative SF-12 PCS (P=0.031), postoperative SF-12 PCS (P=0.007), and postoperative HHS (P=0.005). The postoperative orthopedic complications included delayed wound healing in 28 hips (8.2%), joint noise in 11 hips (3.2%), periprosthetic infection in 3 hips (0.9%), dislocation in 3 hips (0.9%), and periprosthetic fracture in 2 hips (0.6%). All hips were divided into the delayed wound healing group (28 hips) and the normal wound healing group (312 hips). The results of intergroup comparisons revealed significant differences in preoperative SF-12 PCS (P=0.009), postoperative SF-12 MCS (P=0.025), and the proportion of THA using ceramic-on-polyethylene bearing (P=0.009) between the two groups. Multivariate logistic regression analysis indicated that preoperative SF-12 PCS (P=0.014, OR=0.94) and the use of ceramic-on-polyethylene bearing surface (P=0.014, OR=2.90) were associated factors for delayed wound healing after THA. The clinical results of THA reconstruction for the treatment of ONFH in SLE patients were reliable with high level of clinical scores and patient satisfaction. Unfortunately, a relatively high rate of systemic and orthopedic complications, including urinary tract infection and delayed healing of incision, deserved attention. Therefore, the perioperative management regimen should be emphasized in order to minimize the risk of postoperative complications.

  • [A long-term review for radiographic parameters of hips in axial spondyloarthritis patients with end-stage hip involvement: A 24-year trend analysis from a single high-volume tertiary center].

    by Xinfeng Wu, Siliang Man, Dazhao Chen, Yong Hua, Xijie Wen, Yingyue Ding, Liang Zhang, Xiujuan Hou

    To evaluate the characteristics and their change trends of major radiographic parameters of hips in axial spondyloarthritis (axSpA) patients with end-stage hip involvement from a single high-volume tertiary center over a 24-year period. Between 2001 and 2024, the radiographic trends of hips in axSpA patients with end-stage hip involvement were retrospectively reviewed. These radiographic parameters included bony ankylosis, acetabular protrusio, dislocation, obturator foramen ratio (OFR), canal flare index (CFI) and neck shaft angle (NSA). The baseline demographic, disease-related and laboratory parameters before surgery were also collected. Trend analyses over the study period were assessed using the Jonkheere-Terpstra trend test or the Cochran-Armitage trend test for clinical and radiographic parameters. All the joints were divided into the 2001-2012 group and 2013-2024 group according to the year of surgery, and the intergroup comparisons were conducted to further elucidate temporal changes. The overall incidence of bony ankylosis, acetabular protrusio and dislocation before operation were 40.2%, 14.8% and 9.8%, respectively. The median value of OFR, CFI and NSA were 1.5 (1.2, 1.7), 3.2 (2.6, 3.8) and 141.0° (135.0°, 148.0°), respectively. Notably, only the value of OFR demonstrated increasing trend (P=0.001) among these radiographic parameters of hip, although some clinical parameters demonstrated increasing trend [hemoglobin (Hb) (P < 0.001), albumin (ALB) (P < 0.001), short form 12-item health survey (SF-12) physical component summary (PCS) (P=0.005), Harris hip score (HHS) (P=0.003)] or decreasing trend [erythrocyte sedimentation rate (ESR) (P < 0.001), C-reactive protein (CRP) (P < 0.001), Bath ankylosing spondylitis disease activity index (BASDAI) (P=0.013), Bath ankylosing spondylitis functional index (BASFI) (P < 0.001)]. The results of intergroup comparisons between 2001-2012 inpatient group (n=421) and 2013-2024 inpatient group (n=577) showed that no significant differences were found for these radiographic parameters of hip, although some clinical parameters were significantly different, including gender (P=0.004), body mass index (BMI) (P=0.002), age at disease onset (P < 0.001) and HHS (P < 0.001). The radiographic parameters of hip in axSpA patients with end-stage hip involvement did not show a trend of improvement over time, despite observed improvements in disease activity control and functional status. This dissociation between clinical improvement and persistent structural damage presents considerable technical challenges for subsequent surgical reconstruction with total hip arthroplasty.

  • Synovial infiltrating immune cell heterogeneity associated with synovitis severity and systemic disease activity in rheumatoid arthritis: a cross-sectional study

    by Peishi Rao, Shanzhao Jin, Baozhen Zhang, Ru Li, Xiaolin Sun, Liang Zhang, Zhanguo Li

    Background Rheumatoid arthritis (RA) is a systemic autoimmune disorder characterized by persistent synovitis. The synovial inflammation observed in RA exhibits significant heterogeneity among patients. Objective To examine the relationship between major immune cell infiltration profiles in synovium and both local synovitis and systemic manifestations of RA. Methods This cross-sectional study enrolled 22 RA patients (mean disease duration: 7.1 years). Synovial biopsies were assessed using the Krenn synovitis scoring system (no/low/high-grade) and immunohistochemical pathotyping (lympho-myeloid, diffuse-myeloid, pauci-immune). Clinical parameters, including the Disease Activity Score-28 (DAS28), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and autoantibody status, were systematically analyzed. Results Immunohistochemical analysis identified three distinct synovial pathotypes, characterized by specific distributions of CD3⁺ T cells, CD68⁺ macrophages, CD20⁺ B cells, and CD138⁺ plasma cells. Synovitis severity, classified using the Krenn scoring system, demonstrated significant differences in synovial inflammation and stromal hyperplasia. High-grade synovitis exhibited significantly increased infiltration of CD20⁺ B cells (p = 0.025) and CD138⁺ plasma cells (p = 0.034) compared to non-inflamed tissues. Pathotype distribution analysis revealed a predominance of the pauci-immune subtype in the no-synovitis group (59.1%), whereas the lympho-myeloid subtype became progressively more prevalent with increasing synovitis severity (31.8% overall).ESR, CRP, and DAS28, were significantly correlated with synovial immune cell infiltration and synovitis severity, whereas no significant association was observed between synovitis and RA associated autoantibodies such as anti-cyclic citrullinated peptide (anti-CCP) or rheumatoid factor (RF). Conclusion These findings underscore the complex interactions between synovial infiltrating immune cells, synovitis severity, and systemic disease activity, providing valuable insights for the development of personalized RA management strategies. Key Points •This study characterizes synovial immune infiltrates in relation to synovitis severity and systemic disease activity in RA •High-grade synovitis, as assessed by the Krenn scoring system, is associated with increased infiltration of immune cells, such as CD20⁺ B cells and CD138⁺ plasma cells, contributing to more severe inflammation and joint destruction. •The distribution of synovial pathotypes (lympho-myeloid, diffuse-myeloid, pauci-immune) correlates with synovitis severity, providing insights into potential molecular subtypes that could influence clinical phenotypes and treatment responses in RA.


  • Factors predisposing to limited flexion after total hip arthroplasty for the treatment of axial spondyloarthritis

    by Xiaoying Li, Jing Pan, Hongchao Li, Jun Zhang, Feng Pan, Siliang Man, Liang Zhang

    Hip involvement is a common condition in about one-third of patients with axial spondyloarthritis (axSpA). We assessed the incidence of possible factors that predispose patients to limited flexion after total hip arthroplasty (THA) for the treatment of axSpA. We retrospectively reviewed 516 patients with axSpA (759 hips) who underwent THA. Baseline patient demographics and clinical, laboratory, and surgery-related parameters were retrospectively collected. The preoperative and latest follow-up Harris hip score (HHS) and hip flexion ability were compared. After documenting the degree of postoperative hip flexion at the latest follow-up visit, we classified hips into good flexion group (> 90°) and poor flexion group (≤ 90°). The differences of baseline parameters between good flexion and poor flexion group were examined. Then those baseline parameters with P < 0.1 in intergroup comparisons were further included into the multivariate logistic models. The median duration of follow-up was 118.5 months (range, 25.0–269.1 months). The median HHS increased from 36.0 (25.0, 44.0) before surgery to 85.0 (77.0, 92.0) at the latest follow-up visit (P < 0.001). At the latest follow-up visit, 406 hips (53.5%) had hip flexion > 90°. The patients who were somewhat dissatisfied represented 147 hips (19.4%), and those who were very dissatisfied represented 46 hips (6.1%). The primary cause of dissatisfaction was limited range of motion (ROM) (323 hips, 80.1%). The multivariate logistic regression model revealed that the significant variables for postoperative poor hip flexion were the younger age of disease onset (OR = 0.967; P = 0.024), psoriasis (PSO) (OR = 2.071; P = 0.007), elevated C-reactive protein (CRP) (OR = 1.031; P < 0.001), and the lack of direct anterior approach (DAA) (OR = 0.372; P = 0.015). Although THA reconstruction for axSpA patients with end-stage hip involvement achieved encouraging clinical outcomes, it was prone to a restriction of hip flexion, which is closely associated with patient satisfaction. The younger age of disease onset, PSO, elevated CRP and the lack of DAA were significantly associated with limited postoperative hip flexion. Key Points • The restriction of hip flexion after THA reconstruction for axSpA patients is closely associated with patient satisfaction. • The younger age of disease onset, PSO, elevated CRP and the lack of DAA were significantly associated with limited postoperative hip flexion.

  • Open Access

    A Cross-Sectional Study on Gluteal Muscles in Patients with Ankylosing Spondylitis at Different Stages of Hip Involvement

    by Tao Bian, Liang Zhang, Siliang Man, Hongchao Li, Weiyi Li, Yixin Zhou

    Hip involvement in ankylosing spondylitis (AS) is associated with severe functional impairment, and early diagnosis can improve the disease prognosis. We investigated gluteal muscle cross-sectional area (CSA) and radiodensity at different stages of hip involvement and their associations with AS-related clinical and laboratory parameters. This cross-sectional study included 83 patients with AS and 83 age- and sex-matched controls. Patients with AS were divided into three groups according to the Bath Ankylosing Spondylitis Radiology Hip Index system. The CSA and radiodensity of the gluteus maximus, medius, and minimus muscles were measured using computed tomography images. Muscle parameters were compared, and their relationships with clinical and laboratory parameters were evaluated. For the gluteus maximus, patients with AS had a lower CSA than controls, regardless of the degree of hip involvement. For the gluteus medius and minimus, patients with moderate/advanced hip involvement had significantly lower CSA and radiodensity than those with mild to no hip involvement. The severity of hip involvement was negatively associated with muscle parameters. CSA of the gluteus maximus decreased in early-stage hip involvement without any changes in radiographs, while radiodensity decreased in the later stages. Muscle parameters on computed tomography may be a more sensitive indicator than radiographic findings.